News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PharmaNet/i3 Named Distinguished Partner by US-China Anti-Cancer Group



6/28/2012 10:29:15 AM

by Richard Daverman, PhD

June 27, 2012 -- PharmaNet/i3, the clinical-stage CRO division of inVentiv Health, received the Distinguished Partner Award from the US Chinese Anti-Cancer Association (USCACA) for its support of oncology clinical trials and cancer research in China. PharmNet/i3 has conducted 250 clinical trials in Asia and the Pacific Rim. The company has offices in Japan, Korea and China. More details....


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES